Prophylactic Normothermia: Reducing the Risk of Perioperative Shivering.

The Pathophysiology of Perioperative Hypothermia

‍

During induction of general anesthesia, the body undergoes a rapid redistribution of heat from the core to the periphery. Anesthetic agents act as potent vasodilators, inhibiting the hypothalamus from maintaining the standard set point. This "redistribution phase" causes a sharp drop in core temperature within the first hour of surgery.

Once the patient is moved to the PACU, the anesthesia wears off, and the body’s thermoregulatory mechanisms—specifically shivering—return with a vengeance. Shivering is not merely a comfort issue; it is a clinical hazard:

‍

• Metabolic Surge: Shivering can increase oxygen consumption by 200% to 500%.
• Cardiac Stress: The increased demand for oxygen can trigger myocardial stress or ischemia in patients with underlying cardiovascular disease.

• Coagulopathy: Even mild hypothermia impairs platelet function and the coagulation cascade, increasing the risk of perioperative blood loss.
• Delayed Drug Metabolism: Hypothermia slows the metabolism of anesthetic agents, prolonging the time to extubation and increasing the patient's stay in the ICU or PACU.

Limitations of Current Warming Modalities

‍

To combat these risks, surgical teams have traditionally relied on forced-air warming (FAW) blankets or warmed intravenous fluids. While helpful, these methods have significant drawbacks:

‍

1. Surface Warming Inefficiency: Forced-air blankets heat the skin, not the core. In high-stakes surgeries where the patient’s chest or abdomen is open, the surface area available for blankets is severely limited, making it impossible to keep pace with core heat loss.
2. OR Interference: Large blankets and air hoses can obstruct the surgical field, limit access to the patient’s limbs for monitoring, and potentially stir up particulate matter in the sterile field.
3. Lag Time: Intravenous fluids are effective at preventing further cooling but are rarely sufficient to actively re-warm a patient who has already become hypothermic.

The Role of Esophageal Prophylactic Normothermia

‍

Esophageal heat exchange technology offers a "core-first" approach to normothermia. Because the device is placed internally, it bypasses the hurdles of surface-area limitations and surgical field obstructions.

‍

Direct Mediastinal Warming

The esophagus is the ideal site for prophylactic warming. Its proximity to the heart and aorta allows for the direct transfer of thermal energy to the blood before it is pumped to the rest of the body. By circulating warm water through a closed-loop esophageal device, the clinician can counteract the anesthetic-induced heat redistribution in real-time.

‍

Superior Control of the Shivering Threshold

The body’s shivering threshold is tightly regulated. When core temperature drops below approximately 35.5°C, the body initiates shivering. Esophageal warming is highly effective at keeping the core temperature above this critical threshold throughout the entire surgical procedure. By maintaining "true normothermia" (36.5°C to 37.5°C), the patient wakes up in the PACU with a stable metabolic rate, reducing or eliminating the need for pharmacological shivering suppressants like meperidine or clonidine.

‍

Clinical Benefits of Active Internal Warming

‍

Implementing a standardized esophageal warming protocol provides several downstream benefits for the surgical team:

‍

Reduced Surgical Site Infections (SSIs)

Mild hypothermia causes vasoconstriction in the skin, which reduces the delivery of oxygen to surgical tissues. Oxygen is required for neutrophils to kill bacteria effectively. Research consistently shows that patients who are kept normothermic have significantly lower rates of SSIs compared to hypothermic patients.

‍

Enhanced Recovery After Surgery (ERAS) Protocols

Esophageal normothermia fits perfectly into modern ERAS protocols. By reducing the metabolic stress of shivering and ensuring rapid metabolism of anesthetic drugs, patients meet discharge criteria faster. This improves throughput in the PACU and reduces the total cost of the surgical episode.

‍

Intraoperative Accessibility

For surgeons, the esophageal device is invisible once placed. There are no hoses on top of the patient and no bulky blankets to navigate around. This is particularly advantageous in:

• Cardiothoracic Surgery: Where core temperature must be managed precisely without interfering with the chest opening.
• Major Abdominal Surgery: Where forced-air blankets are often pushed so far up the chest that they become ineffective.
• Orthopedic Surgery: Where large sterile fields are required.

Implementation and Safety

‍

The safety profile of esophageal warming is excellent. The closed-loop system ensures that the warming fluid never touches the patient, and the automated control units prevent overheating by utilizing real-time feedback from core temperature probes. Insertion is as simple as placing a standard gastric tube, making it accessible for anesthesiologists and CRNAs during the induction phase.

‍

Conclusion

‍

Prophylactic normothermia is no longer an optional luxury in the OR; it is a critical component of safe perioperative care. Esophageal heat exchange technology represents the most efficient method of maintaining core temperature in the most challenging surgical environments. By moving the warming interface from the skin to the core, clinicians can significantly reduce the risks associated with perioperative shivering, decrease surgical complications, and accelerate patient recovery.